Comparison of the Effects of Pioglitazone versus Placebo when Given in Addition to Standard Insulin Treatment in Patients with Type 2 Diabetes Mellitus Requiring Hemodialysis: Results from the PIOren Study.

Nephron Extra · 2012 · PMC3383235 · PMID 22739963

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, the differences mentioned above did not reach statistical significance.

also in 111,027 other papers

showed a trendno p-value reported

NT-proBNP showed a trend towards a higher level in the PLA group in comparison to the PIO group, but levels fluctuated very strongly during the study.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.